419 related articles for article (PubMed ID: 18990940)
1. Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy.
Peng XH; Qian X; Mao H; Wang AY; Chen ZG; Nie S; Shin DM
Int J Nanomedicine; 2008; 3(3):311-21. PubMed ID: 18990940
[TBL] [Abstract][Full Text] [Related]
2. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
Zhu L; Zhou Z; Mao H; Yang L
Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
[TBL] [Abstract][Full Text] [Related]
3. [Application and advancement of magnetic iron-oxide nanoparticles in tumor-targeted therapy].
Chen Y; Chen BA
Chin J Cancer; 2010 Jan; 29(1):125-8. PubMed ID: 20038325
[TBL] [Abstract][Full Text] [Related]
4. Biomineralized iron oxide-polydopamine hybrid nanodots for contrast-enhanced
Wang Z; Wang Y; Wang Y; Wei C; Deng Y; Chen H; Shen J; Ke H
J Mater Chem B; 2021 Feb; 9(7):1781-1786. PubMed ID: 33594402
[TBL] [Abstract][Full Text] [Related]
5. Interactions of iron oxide nanoparticles with the immune system: challenges and opportunities for their use in nano-oncology.
Baiu DC; Brazel CS; Bao Y; Otto M
Curr Pharm Des; 2013; 19(37):6606-21. PubMed ID: 23621531
[TBL] [Abstract][Full Text] [Related]
6. Receptor-targeted nanoparticles for in vivo imaging of breast cancer.
Yang L; Peng XH; Wang YA; Wang X; Cao Z; Ni C; Karna P; Zhang X; Wood WC; Gao X; Nie S; Mao H
Clin Cancer Res; 2009 Jul; 15(14):4722-32. PubMed ID: 19584158
[TBL] [Abstract][Full Text] [Related]
7. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications.
Gupta AK; Naregalkar RR; Vaidya VD; Gupta M
Nanomedicine (Lond); 2007 Feb; 2(1):23-39. PubMed ID: 17716188
[TBL] [Abstract][Full Text] [Related]
8. Magnetic iron oxide nanoparticles for tumor-targeted therapy.
Chen B; Wu W; Wang X
Curr Cancer Drug Targets; 2011 Feb; 11(2):184-9. PubMed ID: 21158723
[TBL] [Abstract][Full Text] [Related]
9. Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles.
Sun C; Fang C; Stephen Z; Veiseh O; Hansen S; Lee D; Ellenbogen RG; Olson J; Zhang M
Nanomedicine (Lond); 2008 Aug; 3(4):495-505. PubMed ID: 18694312
[TBL] [Abstract][Full Text] [Related]
10. Promising approaches in using magnetic nanoparticles in oncology.
Mikhaylov G; Vasiljeva O
Biol Chem; 2011 Nov; 392(11):955-60. PubMed ID: 21848508
[TBL] [Abstract][Full Text] [Related]
11. A multimodal magnetic resonance imaging nanoplatform for cancer theranostics.
Benyettou F; Lalatonne Y; Chebbi I; Di Benedetto M; Serfaty JM; Lecouvey M; Motte L
Phys Chem Chem Phys; 2011 Jun; 13(21):10020-7. PubMed ID: 21409252
[TBL] [Abstract][Full Text] [Related]
12. A novel anti-VEGF targeting and MRI-visible smart drug delivery system for specific diagnosis and therapy of liver cancer.
Huang H; Li Y; Li C; Wang Y; Sun Y; Wang J
Macromol Biosci; 2013 Oct; 13(10):1358-68. PubMed ID: 23852809
[TBL] [Abstract][Full Text] [Related]
13. Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery.
Choi H; Choi SR; Zhou R; Kung HF; Chen IW
Acad Radiol; 2004 Sep; 11(9):996-1004. PubMed ID: 15350580
[TBL] [Abstract][Full Text] [Related]
14. Biofunctionalized, phosphonate-grafted, ultrasmall iron oxide nanoparticles for combined targeted cancer therapy and multimodal imaging.
Das M; Mishra D; Dhak P; Gupta S; Maiti TK; Basak A; Pramanik P
Small; 2009 Dec; 5(24):2883-93. PubMed ID: 19856326
[TBL] [Abstract][Full Text] [Related]
15. Iron-oxide-based twin nanoplates with strong T
Wei R; Zhou T; Sun C; Lin H; Yang L; Ren BW; Chen Z; Gao J
Nanoscale; 2018 Oct; 10(38):18398-18406. PubMed ID: 30256373
[TBL] [Abstract][Full Text] [Related]
16. Facile one-pot fabrication of calcium phosphate-based composite nanoparticles as delivery and MRI contrast agents for macrophages.
Nakamura M; Oyane A; Kuroiwa K; Shimizu Y; Pyatenko A; Misawa M; Numano T; Kosuge H
Colloids Surf B Biointerfaces; 2018 Feb; 162():135-145. PubMed ID: 29190464
[TBL] [Abstract][Full Text] [Related]
17. Imaging the delivery of brain-penetrating PLGA nanoparticles in the brain using magnetic resonance.
Strohbehn G; Coman D; Han L; Ragheb RR; Fahmy TM; Huttner AJ; Hyder F; Piepmeier JM; Saltzman WM; Zhou J
J Neurooncol; 2015 Feb; 121(3):441-9. PubMed ID: 25403507
[TBL] [Abstract][Full Text] [Related]
18. Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging.
Yang L; Mao H; Wang YA; Cao Z; Peng X; Wang X; Duan H; Ni C; Yuan Q; Adams G; Smith MQ; Wood WC; Gao X; Nie S
Small; 2009 Feb; 5(2):235-43. PubMed ID: 19089838
[TBL] [Abstract][Full Text] [Related]
19. Magnetic core-shell hybrid nanoparticles for receptor targeted anti-cancer therapy and magnetic resonance imaging.
Shanavas A; Sasidharan S; Bahadur D; Srivastava R
J Colloid Interface Sci; 2017 Jan; 486():112-120. PubMed ID: 27697648
[TBL] [Abstract][Full Text] [Related]
20. Current Status of Magnetite-Based Core@Shell Structures for Diagnosis and Therapy in Oncology Short running title: Biomedical Applications of Magnetite@Shell Structures.
Andrade AL; Fabris JD; Domingues RZ; Pereira MC
Curr Pharm Des; 2015; 21(37):5417-33. PubMed ID: 26377654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
